INTRAVENOUS NICORANDIL THERAPY REDUCES MATRIX METALLOPROTEINASE-2 IN PATIENTS WITH ACUTE HEART FAILURE SYNDROMES

Authors :: Minoru Ichikawa
Takeshi Hata
Yusuke Nakagawa
Kuniyasu Ikeoka
Shuichi Ishizuka
Akira Nishibe
Akiko Matsuo
Yoshiyuki Kijima
Megumi Kunishige
Source :: Journal of the American College of Cardiology. 57:E257
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: medicine.medical_specialty
business.industry
Matrix metalloproteinase
medicine.disease
Internal medicine
Heart failure
cardiovascular system
medicine
Cardiology
In patient
Cardiology and Cardiovascular Medicine
Nicorandil
business
medicine.drug

Full Text Access

Tools